Figure 5From: Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritisParallel changes in SLEDAI, sMer and C1q related to disease activity. The SLEDAI and sMer concentrations decrease, whereas the C1q levels increase after therapy.Back to article page